GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$83.41
+0.39% today
Updated 2026-04-29
Market cap
$11.06B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$36 – $121
Volume
2.0M
Guardant Health Inc (GH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+41.8%
Last 4 quarters
Revenue YoY growth
+39.4%
Most recent quarter
EPS YoY growth
+19.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.8%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+32.8%
2025-10-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $-0.50 | +35.5% | $107.42 | $103.10 | -4.0% |
| 2025-10-29 | $-0.39 | +50.6% | $69.58 | $92.41 | +32.8% |
| 2025-07-30 | $-0.44 | +38.9% | $43.32 | $40.98 | -5.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.78 | $-0.50 | +35.5% | $281.27M | +39.4% |
| 2025-09-30 | $-0.79 | $-0.39 | +50.6% | $265.20M | +38.5% |
| 2025-06-30 | $-0.72 | $-0.44 | +38.9% | $232.09M | +30.9% |
| 2025-03-31 | $-0.85 | $-0.49 | +42.4% | $203.47M | +20.8% |
| 2024-12-31 | $-0.50 | $-0.62 | -23.1% | $201.81M | +30.2% |
| 2024-09-30 | $-0.74 | $-0.88 | -18.9% | $191.48M | +33.9% |
| 2024-06-30 | $-0.74 | $-0.84 | -13.5% | $177.24M | +29.2% |
| 2024-03-31 | $-0.85 | $-0.94 | -10.6% | $168.49M | +30.9% |
| 2023-12-31 | $-0.86 | $-0.85 | +1.2% | $155.05M | — |
| 2023-09-30 | $-0.95 | $-0.73 | +23.2% | $143.03M | — |
| 2023-06-30 | $-1.18 | $-0.67 | +43.2% | $137.15M | — |
| 2023-03-31 | $-1.32 | $-1.30 | +1.5% | $128.71M | — |
Frequently asked questions
Has Guardant Health Inc beaten earnings estimates?
Guardant Health Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +41.8% over the last 4 quarters.
How does GH stock react to earnings?
GH stock has moved an average of +7.8% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Guardant Health Inc's revenue growth rate?
Guardant Health Inc reported year-over-year revenue growth of +39.4% in its most recent quarter, with EPS growing +19.4% year-over-year.